Navigation Links
Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
Date:10/10/2007

nfused over 10 minutes. After 15 minutes, a second 10 minute infusion of vernakalant 2 mg/kg or placebo was given if AF persisted or atrial flutter was present. The primary efficacy measure was the percentage of patients demonstrating conversion to SR for at least one minute within 90 minutes of dosing. Patients demonstrating conversion within 90 minutes were categorized as responders. Other efficacy measures included median time to conversion and the percentage of patients still in sinus rhythm at hour 24 and day 7.

In this subanalysis, a significantly higher percentage of patients with acute AF given vernakalant (61.8 percent) demonstrated conversion to SR within 90 minutes compared to patients given placebo (5.1 percent), P<.0001. Conversion from AF to SR with vernakalant was rapid and sustained. Among vernakalant responders, median conversion time was 11 minutes, and SR was maintained for 24 h in 97 percent and for 7 days in 93 percent. Seventy-eight percent of vernakalant responders required only one dose of the drug.

The most common adverse events (AEs) in patients given vernakalant were taste disturbance (32.4 percent), sneezing (16.7 percent), nausea (15.7 percent) and dizziness (11.8 percent). The incidence of serious AEs was similar in the vernakalant and placebo treatment groups for both the entire period and the first 24 hours (11.8 percent vs. 15.3 percent and 3.9 percent vs. 1.7 percent, respectively).

About Atrial Fibrillation

Atrial fibrillation (AF) is an interruption of the normal sinus rhythm (arrhythmia) of the heart in which the atria, the two uppermost chambers of the heart, beat irregularly and at an extremely rapid rate.(1) During AF, rapid and uncoordinated electrical discharges are generated by the heart's natural pacemaker (sinoatrial node) and other parts of the atria. This causes ineffective contractions of the atria and reduces the ability of the heart to pump blood through the body. Symptoms include dizziness, h
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
6. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
7. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
10. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
11. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) ... received a written notice (the "Notice") executed by the ... of the Company, requesting that the Board of Directors ... for stockholder action by written consent relating to the ... director seat resulting from Ronald J. Kanterman,s departure (the ...
(Date:12/15/2009)... Ever wonder what something looks like up close and ... Personal Scanning Electron Microscope (PSEM), kicked off its "Send ... samples to be scanned by one of their PSEMs. ... of 100nm to 5mm and an imaging resolution of ... In addition, ASPEX will not only scan your sample, ...
(Date:12/15/2009)... the best plan at the right price ... end of the year, thousands of Nebraska Medicare beneficiaries ... This is when the state,s 268,000 Medicare beneficiaries ... up and pay for in 2010. ,, Prescription ... says Independent Retail Pharmacist Steve Osenbaugh, of Lincoln. ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2LenSar 3A New Laser Cure for Cataracts 6005 1LenSar 3A New Laser Cure for Cataracts 6005 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 1BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 4Houston and New York Cosmetic Dermatologist Paul M Friedman MD Launches Expansive New Website 60745 1Houston and New York Cosmetic Dermatologist Paul M Friedman MD Launches Expansive New Website 60745 2Houston and New York Cosmetic Dermatologist Paul M Friedman MD Launches Expansive New Website 60745 3
... Several new studies presented at the American Urological ... use of statins--commonly prescribed to lower cholesterol--may benefit men ... symptoms (LUTS). Several key research studies highlighting these benefits ... media on Monday, April 27 from 9 to ...
... Study for the Treatment of Advanced Prostate CancerPARSIPPANY, N.J., ... of a Phase IIIB clinical trial of degarelix for ... approved by the U.S. Food and Drug Administration (FDA) ... The announcement was made at the ...
Other Medicine Technology:New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 3Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 4Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 5
(Date:12/16/2009)... 16 For ages, people from around the ... properties. Its soothing waters have a reputation that dates ... involvement with miracles. Now, with the introduction of two ... can enjoy the legendary benefits of Dead Sea salt ... lines contain all-natural Dead Sea salt and essential oils ...
(Date:12/16/2009)... More Americans have myopia now than in the ,70s, ... Myopia (nearsightedness) is more common in the United States ... National Eye Institute study shows. , Researchers compared National ... and white participants from 1971 to 1972 and from ... The participants were 12 to 54 years old. , ...
(Date:12/16/2009)... trial bottle sample with purchase of 90-count bottle. , ... ... announces a special free offer for a “Free 21-Count ... Formula , with the purchase of a 90-count bottle. Distributed ... in FDA approved facilities and blends the 6 most important medicinal ...
(Date:12/16/2009)... Request A Test, Ltd. is proud to announce being presented with ... Weatherhead 100 showcases the fastest growing companies in Northeast Ohio and ... to succeed. , ... (PRWEB) December ... being presented with the Weatherhead 100 Upstart Award on December 3, ...
(Date:12/16/2009)... perfect gift to give that special woman who has everything? ... Mary Schook introduces exceptional beauty products online while educating the public ... ... (PRWEB) December 16, 2009 -- The holidays are rapidly approaching ... woman who has everything? Why stem cells, of course!, , , ...
Breaking Medicine News(10 mins):Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2
... CUR, QUEBEC CITY, June 3 /PRNewswire-FirstCall/ - Two ... the detection of prostate cancer,and GCC for the staging ... part of the growing trend to molecular diagnostics., ... the 34th,Annual International Clinical Ligand Assay Society Meeting, held ...
... Trainers For Peak ... Performance, LOS ANGELES, June 2 ... Cher, now the,Pussycat Dolls are working out with Bally. On the verge of ... for,their hot new single "When I Grow Up," the Pussycat Dolls are getting ...
... Gentiva Health,Services, Inc. (Nasdaq: GTIV ), the ... today that it has acquired,Physicians Home Health Care ... $12 million in cash. The transaction will be ... established by a group of physicians in 1984, ...
... of autoantibody-secreting cells, have emerged as promising new ... (RA). In particular, B cell depletion with ... RA patients resistant to standard disease-modifying antirheumatic drugs ... In large trials, about half of these ...
... 2 The International Rett Syndrome,Foundation announced today ... Chief Scientific Officer, beginning July 1. Dr. Horton ... of Rett,Clinics, a series of clinics throughout the ... addition, Dr. Horton will,assist the IRSF Board of ...
... There is still time to enter,the American Academy ... to boys and girls in two groups, grades 3-5 ... will be invited to attend,the 2008 AAP National Conference ... winners will receive $500 and up to $1,000 for ...
Other Medicine News:Health News:DiagnoCure's molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings 2Health News:DiagnoCure's molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings 3Health News:Pussycat Dolls Shape Up With Bally Total Fitness 2Health News:Gentiva(R) Health Services Acquires Leading Colorado Home Health Provider 2Health News:Gentiva(R) Health Services Acquires Leading Colorado Home Health Provider 3Health News:Study of anti-CD20 therapy effective B cell depletion 2Health News:The International Rett Syndrome Foundation Names Antony Horton Ph.D. Chief Scientific Officer 2
MP-250N and 300N is a new style power supply. It is a versatile microprocessor power supply for horizontal or vertical gel electrophoresis. The unit is programmable and offers constant voltage and co...
Handy 100V Power Supply is Low-cost, compact and lightweight. Easy to operate - either 50 or 100 VDC is selectable as the output voltage. These voltages are sufficient for ordinary electrophoresis....
... ZOOM® Dual Power is a microprocessor-controlled ... both high voltage/low current and high ... voltage/low current section is ideal for ... DNA sequencing applications. The low voltage/high ...
... Power Supply is designed specifically ... extensive programming capabilities, including eight ... for you to set to ... intuitive PowerEase® interface is faster ...
Medicine Products: